Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5330_Библиотеки_им_академика_М_И_Перельмана
.pdf
84
https://t.me/medicina_free
Y. A. T. Ngandjui et al.
104. Ye B, Chen X, Dai S, Han J, Liang X, Lin S, Cai X, Huang Z,
Huang W. Emodin alleviates myocardial ischemia/reperfusion
injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Dev Ther. 2019;13:975–90.
105. Pang H, Han B, Yu T, Peng Z.The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy. PLoS One. 2014;9:e92216.
106. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki
H, Kimura I. Ameliorating effects of compounds derived from
Salvia miltiorrhiza root extract on microcirculatory disturbance
and target organ injury by ischemia and reperfusion. Pharmacol
Ther. 2008;117:280–95.
107. Chen J, Xie J, Jiang Z, Wang B, Wang Y, Hu X. Shikonin and its
analogs inhibit cancer cell glycolysis by targeting tumor pyruvate
kinase -M2. Oncogene 2011;30:4297–4306.
108. Lyu X, Lee J, Chen WN.Potential natural food preservatives and
their sustainable production in yeast: terpenoids and polyphenols.
J Agric Food Chem. 2019;67:4397–417.
109. Zaini R, Clench MR, Le Maitre CL.Bioactive chemicals from carrot (Daucus carota) juice extracts for the treatment of leukemia. J
Med Food. 2011;(14):1303–12.
110. Li R, Lu K, Wang Y, Chen M, Zhang F, Shen H, Yao D, Gong
K, Zhang Z. Triptolide attenuates pressure overload-induced
myocardial remodeling in mice via the inhibition of NLRP3
inammasome expression. Biochem Biophys Res Commun.
2017;485:69–75.
111. Guo X, Xue M, Li CJ, Yang W, Wang S-S, Ma Z-J, Zhang X-n,
Wang X-y, Zhao R, Chang B-c, Chen L-m. Protective effects
of triptolide on TLR4 mediated autoimmune and inammatory
response induced myocardial brosis in diabetic cardiomyopathy.
J Ethnopharmacol. 2016;193:333–44.
112. Wang KS, Li J, Wang Z, Mi C, Ma J, Piao LX, Xu GH, Li X,
Jin X. Artemisinin inhibits inammatory response via regulating NF-κB and MAPK signaling pathways. Immunopharmacol
Immunotoxicol. 2017;39:28–36.
113. Xiong Z, Sun G, Zhu C, Cheng B, Zhang C, Ma Y, Dong
Y.Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling. Eur J Pharmacol.
2010;649:277–84.
114. Wang QS, Gao T, Cui YL, Gao LN, Jiang HL.Comparative studies of paeoniforin and albiforin from Paeonia lactifora on anti-
inammatory activities. Pharm Biol. 2014;52:1189–95.
115. Zhou P, Yang X, Jia X, Yu J, Asenso J, Xiao F, Wang C, Wei
W. Effect of 6′-acetylpaeoniforin on dinitrochlorobenzeneinduced allergic contact dermatitis in BALB/c mice. Immunol
Res. 2016;64:857–68.
116. Li JZ, Xie M, Mo D, Zhao XF, Yu S-Y, Liu L-J, Wu C, Yang
Y. Picroside II protects myocardium from ischemia/reperfusioninduced injury through inhibition of the inammatory response.
Exp Ther Med. 2016;12:3507–14.
117. Chen RC, Wang J, Yang L, Sun GB, Sun XB.Protective effects of
ginsenoside Re on lipopolysaccharide-induced cardiac dysfunction in mice. Food Funct. 2016;7:2278–87.
118. Wang QW, Yu XF, Xu HL, Jiang YC, Zhao XZ, Sui DY.Ginsenoside
Re attenuates isoproterenol-induced myocardial injury in rats.
Evid Based Complement Alternat Med. 2018;2018:8637134.
119. Chen CT, Wang ZH, Hsu CC, Lin HH, Chen JH.In vivo protective
effects of diosgenin against doxorubicin-induced cardiotoxicity.
Nutrients. 2015;7:4938–54.
120. Zhang R, Han D, Li Z, Shen C, Zhang Y, Li J, Yan G, Li S, Hu
B, Li J, Liu P. Ginkgolide C alleviates myocardial ischemia/
reperfusion- induced inammatory injury via inhibition of CD40NF- κB pathway. Front Pharmacol. 2018;9:109.
121. Su S, Li Q, Liu Y, Xiong C, Li J, Zhang R, Niu Y, Zhao L, Wang
Y, Guo H. Sesamin ameliorates doxorubicin-induced cardiotox-
icity: involvement of Sirt1 and Mn-SOD pathway. Toxicol Lett.
2014;224:257–63.
122. Chung SY. Method for preparing extract for the prevention and
treatment of hyperlipidemia and obesity from the extract of Aster
spathulifolius aerial part and composition containing the same.
(US20090232912A1). 2009. [cited 2023 Jan 29]. https://patents.
google.com/patent/US20090232912A1/en?oq=US2009232912+.
123. Xiuhua Z.Medicine composition for treating coronary heart disease and preparation method thereof. 2015. [cited 2023 Jan 29].
https://worldwide.espacenet.com/publicationDetails/biblio?FT=
D&date=20151223&DB=&locale=en_EP&CC=CN&NR=10516
8396A&KC=A&ND=4.
124. Gao Y, Su Y, Huo Y, Mi J, Wang X, Wang Z, Liu Y, Zhang
H. Identication of antihyperlipidemic constituents from
the roots of Rubia yunnanensis Diels. J Ethnopharmacol.
2014;155:1315–21.
125. Wang M, Huang W, Hu Y, Zhang L, Shao Y, Wang M, Zhang F,
Zhao Z, Mei X, Li T, Wang D, Liang Y, Li J, Huang Y, Zhang
L, Xu T, Song H, Zhong Y, Lu B. Phytosterol proles of common foods and estimated natural intake of different structures and
forms in China. J Agric Food Chem. 2018;66:2669–76.
126. Ramachandran V, Saravanan R, Senthilraja P. Antidiabetic and
antihyperlipidemic activity of asiatic acid in diabetic rats, role
of HMG CoA: invivo and in silico approaches. Phytomedicine.
2014;21:225–32.
127. Valsta L, Lemström A, Ovaskainen M-L, Lampi A-M, Toivo J,
Korhonen T, Piironen V.Estimation of plant sterol and cholesterol
intake in Finland: quality of new values and their effect on intake.
Br J Nutr. 2004;92:671–8.
128. Klingberg S, Andersson H, Mulligan A, Bhaniani A, Welch A,
Bingham S, Khaw K-T, Andersson S, Ellegard L.Food sources
of plant sterols in the EPIC Norfolk population. Eur J Clin Nutr.
2008;62:695–703.
129. Rios MY, Lopez-Martinez S, Lopez-Vallejo F, etal. Vasorelaxant
activity of some structurally related triterpenic acids from
Phoradendron reichenbachianum (Viscaceae) mainly by
NO production: ex vivo and in silico studies. Fitoterapia.
2012;83(6):1023–9.
130. Chan C, Mong M, Liu W, Huang C, Yin M.Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucoseinduced injury. Free Radic Res. 2014;48(4):402–11.
131. Der Sarkissian S, Cailhier JF, Borie M, Stevens L-M, Gaboury
L, Mansour S, Hamet P, Noiseux N.Celastrol protects ischaemic
myocardium through a heat shock response with up-regulation of
haeme oxygenase-1. Br J Pharmacol. 2014;171(23):5265–79.
132. Bai Y, Wang X, Zhao S, Ma C, Cui J, Zheng Y.Sulforaphane protects against cardiovascular disease via Nrf2 activation. Oxid Med
Cell Longev. 2015;2015:407580.
133. Barbara VH, David K.Phytochemicals and cardiovascular disease. Circulation. 2021;95:2591–3.
134. Chin YW, Balunas MJ, Chai HB, Kinghorn AD.Drug discovery
from natural sources. AAPS J. 2006;8:E239–53.
135. Burger T, Mokoka T, Fouché G, Steenkamp P, Steenkamp V,
Cordier W. Solamargine, a bioactive steroidal alkaloid isolated
from Solanum aculeastrum induces non-selective cytotoxicity
and P-glycoprotein inhibition. BMC Complement Altern Med.
2018;18:137.
136. Tauchen J, Huml L, Bortl L, Doskocil I, Jarosova V, Marsik P,
Frankova A, Peralta CZM, Zans C, Havlik M-EJ.Screening of
medicinal plants traditionally used in Peruvian Amazon for
in vitro antioxidant and anticancer potential. Nat Prod Res.
2019;33:2718–21.
137. Frédérich M, Tits M, Angenot L, Greimers R, Gielen J, Bours
V, Merville M-P. Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell
Chemical Characterization ofPhytoconstituents forLifestyle Diseases
https://t.me/medicina_free
85
cycle arrest and apoptosis in human colon cancer cells. JPET.
2003;304(3):1103–10.
138. Shoeb M, MacManus SM, Jaspars M, Trevidu J, Nahar L, KongThoo- Lin P, Sarker SD.Montamine, a unique dimeric indole alkaloid, from the seeds of Centaurea montana (Asteraceae), and its
invitro cytotoxic activity against the CaCo2 colon cancer cells.
Tetrahedron. 2006;62:11172–7.
139. Oh J, Kim GD, Kim S, Lee SK.Antone, a natural phenanthroindoloizine alkaloid, suppresses angiogenesis via regulation of
AKT/mTOR and AMPK pathway in endothelial cells and endothelial progenitor cells derived from mouse embryonic stem cells.
2017;107:201–7.
140. Yaffe PB, Coombs PMR, Doucette CD, Walsh M, Hoskin
DW. Piperine, an alkaloid from black pepper, inhibits growth
of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog. 2015;54:
1070–85.
141. Singh S, Verma M, Malhotra M, Prakash S, Singh TD.Cytotoxicity
of alkaloids isolated from Argemone mexicana on SW480 human
colon cancer cell line. Pharm Biol. 2016;54:740–5.
142. Liby KT, Yore MM, Sporn MB.Triterpenoids and rexinoids as
multifunctional agents for the prevention and treatment of cancer.
Nat Rev Cancer. 2007;7:357–69.
143. Abdul-Hameed ZH, Bawakid NO, Alor HS, Sobahi TR, Alburae
NA, Abdel-Lateff A, Elbehairi SEI, Alfai MY, Alhakamy NA,
Alarif WM.Monoterpene indole alkaloids from the aerial parts of
Rhazya stricta induce cytotoxicity and apoptosis in human adenocarcinoma cells. Molecules. 2022;27:1422.
144. Mishra DP, Khan MA, Yadav DK, Rawat AK, Singh RK, Ahamad
T, Hussain MK, Saquib M, Khan MF.Monoterpene indole alkaloids from Anthocephalus cadamba fruits exhibiting anticancer
activity in human lung cancer cell line H1299. ChemistrySelect.
2018;3:8468–72.
145. Zhang W, Jiang H, Chen Y, Ren F.Resveratrol chemosensitizes
adriamycin-resistant breast cancer cells by modulating miR122- 5p. J Cell Biochem. 2019;120(9):1628.
146. Deng L, Wu X, Zhu X, Yu Z, Liu Z, Wang J, Zheng Y.Combination
effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous
cell carcinoma. Am J Transl Res. 2021;13(1):57–72.
147. Yuan CH, Horng CT, Lee CF, Chiang NN, Tsai FJ, Lu CC,
Chiang J-H, Hsu Y-M, Yang J-S, Chen F-A.Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis
and autophagy through stimulating AKT/STAT3 pathway and
suppressing multidrug resistance 1 signaling. Environ Toxicol.
2017;32(3):845–55.
148. Wei F, Jiang X, Gao HY, Gao SH.Liquiritin induces apoptosis and
autophagy in cisplatin (DDP)-resistant gastric cancer cells invitro
and xenograft nude mice invivo. Int J Oncol. 2017;51(5):1383–94.
149. Kubina R, Iriti M, Kabala-Dzik A.Anticancer potential of selected
avonols: setin, kaempferol, and quercetin on head and neck
cancers. Nutrients. 2021;13:845.
150. Ha TK, Jung I, Kim ME, Bae SK, Lee JS.Anti-cancer activity of
myricetin against human papillary thyroid cancer cells involves
mitochondrial dysfunction-mediated apoptosis. 2017;91:378–84.
151. Byun S, Lee KW, Jung SK, Lee EJ, Hwang MK, Lim SH, Bode
AM, Lee HJ, Dong Z.Luteolin inhibits protein kinase C (epsilon)
and c-Src activities and UVB-induced skin cancer. Cancer Res.
2010;70:2415–23.
152. Prakash V. Terpenoids as cytotoxic compounds: a perspective.
Phcog Rev. 2018;12:166–76.
153. Xu W, Li T, Qiu JF, Wu SS, Huang MQ, Lin L-G, Zhang Q-W,
Chen X-P, Lu J-J.Anti-proliferative activities of terpenoids isolated from Alisma orientalis and their structure-activity relationships. Anticancer Agents Med Chem. 2015;15:228–35.
154. Fan D, Parhira S, Zhu GY, Jiang ZH, Bai LP.Triterpenoids from
the stems of Tripterygium regelii. Fitoterapia. 2016;113:69–73.
155. Liu Q, Ahn JH, Kim SB, Lee C, Hwang BY, Lee MK.Sesquiterpene
lactones from the roots of Lindera strychnifolia. Phytochemistry.
2013;87:112–8.
156. Wu J, Yang G, Zhu W, Wen W, Zhang F, Yuan J, An L. Antiatherosclerotic activity of platycodin D derived from roots of
Platycodon grandiorum in human endothelial cells. Biol Pharm
Bull. 2012;35:1216–21.
157. Kikuchi T, Akihisa T, Tokuda H, Ukiya M, Watanabe K, Nishino
H. Cancer chemopreventive effects of cycloartane-type and
related triterpenoids in invitro and invivo models. J Nat Prod.
2007;70:918–22.
158. Pasi S, Aligiannis N, Pratsinis H, Skaltsounis AL, Chinou
IB.Biologically active triterpenoids from Cephalaria ambrosioi-
des. Planta Med. 2009;75:163–7.
159. Wang S, Li J, Sun J, Zeng KW, Cui J-R, Jiang Y, Tu P-F. NO
inhibitory guaianolide-derived terpenoids from Artemisia argyi.
Fitoterapia. 2013;85:169–75.
160. Ou-Yang DW, Wu L, Li YL, Yang PM, Kong DY, Yang XW,
et al. Miscellaneous terpenoid constituents of Abies nephrolepis and their moderate cytotoxic activities. Phytochemistry.
2011;72:2197–204.
161. Huang J, Han HY, Li GY, Wang HY, Zhang C, Zhang K, Tan Y,
Li P-Y, Wang J-H.Two new terpenoid benzoates with antitumor
activity from the roots of Ferula dissecta. J Asian Nat Prod Res.
2013;15:1100–6.
162. Chaipukdee N, Kanokmedhakul K, Kanokmedhakul S, Lekphrom
R, Pyne SG.Two new bioactive iridoids from Rothmannia wittii.
Fitoterapia. 2016;113:97–101.
163. Bakarnga-Via I, Hzounda JB, Fokou PV, Tchokouaha LR, GaryBobo M, Gallud A, Garcia M, Walbadet L, Secka Y, Dongmo
PMJ, Boyom FF, Menut C.Composition and cytotoxic activity of
essential oils from Xylopia aethiopica (Dunal) A. Rich, Xylopia
parviora (A. Rich) benth.) and Monodora myristica (Gaertn)
growing in chad and Cameroon. BMC Complement Altern Med.
2014;14:125.
164. Calvaruso M, Pucci G, Musso R, Bravatà V, Cammarata FP,
Russo G, Forte GI, Minafra L.Nutraceutical compounds as sensitizers for cancer treatment in radiation therapy. Int J Mol Sci.
2019;20:5267.
165. WHO.Chronic respiratory disease. 2009.
166. Zhao YL, Yang ZF, Wu BF, Shang JH, Liu YP, Wang XH, Luo
XD. Indole alkaloids from leaves of Alstonia scholaris (L.)
R. Br. protect against emphysema in mice. J Ethnopharmacol.
2020;259:112949.
167. Tewa XN, Laua NJX, Chellappanb DK, Madheswaranc T,
Zeeshanc F, Tambuwalad MM, Aljabalie AAA, Balusamyf SR,
Perumalsamyg H, Guptah G, Oliveri BG, Hsui A, Warki P, Reddyi
K, Wadhwak R, Hansbrok PM, Dua K.Immunological axis of berberine in managing inammation underlying chronic respiratory
inammatory diseases. Chem Biol Interact. 2020;317:108947.
168. Wang Q, Cui Y, Wu X, Wang J.Evodiamine protects against airway remodelling and inammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway. Pharm Biol.
2021;59:192–9.
169. Silberberg M, Morand C, Mathevon T, Bessong C, Manach C,
Scalbert A, Remesy C. The bioavailability of polyphenols is
highly governed by the capacity of the intestine and of the liver to
secrete conjugated metabolites. Eur J Nutr. 2006;45:88–96.
170. Dragonieri S, Tongoussouva O, Zanini A, Imperatori A,
Spanevello A. Markers of airway inammation in pulmonary
diseases assessed by induced sputum. Monaldi Arch Chest Dis.
2016;71:119–26.
86
https://t.me/medicina_free
Y. A. T. Ngandjui et al.
171. Bargagli E, Olivieri C, Bennett D, Prasse A, Muller-Quernheim
J, Rottoli P.Oxidative stress in the pathogenesis of diffuse lung
diseases: a review. Respir Med. 2009;103:1245–56.
172. Lee M, Kim S, Kwon O-K, Oh S-R, Lee H-K, Ahn K.Antiinammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int
Immunopharmacol. 2009;9:418–24.
173. Liu H, Ren J, Chen H, Huang Y, Li H, Zhang Z, Wang
J.Resveratrol protects against cigarette smoke-induced oxidative
damage and pulmonary inammation. J Biochem Mol Toxicol.
2014;28:465–71.
174. Venkatesan N, Punithavathi D, Babu M. Protection from acute
and chronic lung diseases by curcumin. In: The molecular targets
and therapeutic uses of curcumin in health and disease. Springer;
2007. p.379–405.
175. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman
I.Curcumin induces glutathione biosynthesis and inhibits NF-κB
activation and interleukin-8 release in alveolar epithelial cells:
mechanism of free radical scavenging activity. Antioxid Redox
Signal. 2005;7:32–41.
176. Nanua S, Zick SM, Andrade JE, Sajjan US, Burgess JR, Lukacs
NW, Hershenson MB.Quercetin blocks airway epithelial cell chemokine expression. Am J Respir Cell Mol Biol. 2006;35:602–10.
177. Ying B, Yang T, Song X, Hu X, Fan H, Lu X, Chen L, Cheng D,
Wang T, Liu D, Xu D, Wie Y, Wen F.Quercetin inhibits IL-1 betainduced ICAM-1 expression in pulmonary epithelial cell line A549
through the MAPK pathways. Mol Bio Rep. 2009;36:1825–32.
178. Li G-X, Chen Y-K, Hou Z, Xiao H. Pro-oxidative activities and
dose–response relationship of (-)-epigallocatechin-3-gallate in the
inhibition of lung cancer cell growth: a comparative study invivo
and invitro. Carcinogenesis. 2010;31:902–10.
179. Sadava D, Whitlock E, Kane SE. The green tea polyphenol,
epigallocatechin- 3- gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res
Commun. 2007;360:233–7.
180. Liu MH, Lin AH, Lee HF, Ko HK, Lee TS, Kou YR. Paeonol
attenuates cigarette smoke-induced lung inammation by inhibiting ROS-sensitive inammatory signaling. Mediators Inamm.
2014;2014:651890.
181. Favarin CD, Teixeira MM, de Andrade LE, de Freitas Alves C,
Lazo Chica JE, Arterio Sorgi C, Faccioli LH, Rogerio PA.Antiinammatory effects of ellagic acid on acute lung injury induced
by acid in mice. Mediators Inamm. 2013;2013:164202.
182. Wei M, Chu X, Jiang L, Yang X, Cai Q, Zheng C, Ci X, Guan M,
Liu J, Deng X.Protocatechuic acid attenuates lipopolysaccharideinduced acute lung injury. Inammation. 2012;35:1169–78.
183. Ganesan S, Faris AN, Comstock AT, Chattoraj S, Chattoraj A,
Burgess JR, Curtis JL, Martinez FJ, Zick S, Hershenson MB,
Sajjan U.Quercetin prevents progression of disease in elastase/
LPS-exposed mice by negatively regulating MMP expression.
Respir Res. 2010;11:131.
184. Li L, Bao H, Wu J, Duan X, Liu B, Sun J, Gong W, Lv Y, Zhang
H, Luo Q, Wu X, Dong J.Baicalin is antiinammatory in cigarette smoke-induced inammatory models invivo and invitro:
a possible role for HDAC2 activity. Int Immunopharmacol.
2012;13:15–22.
185. Nie YC, Wu H, Li PB, Luo YL, Long K, Xie LM, Shen JG, Su
WW.Anti-inammatory effects of naringin in chronic pulmonary
neutrophilic inammation in cigarette smoke exposed rats. J Med
Food. 2012;15:894–900.
186. Chi G, Wei M, Xie X, Soromou LW, Liu F, Zhao S.Suppression
of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inammatory responses in
acute lung injury. Inammation. 2013;36:501–11.
187. Bai GZ, Yu HT, Ni YF, Li XF, Zhang ZP, Su K, Lei J, Liu BY,
Ke CK, Zhong DX, Wang YJ, Zhao JB. Shikonin attenuates
lipopolysaccharide- induced acute lung injury in mice. J Surg Res.
2013;182:303–11.
188. Yingkun N, Zhenyu W, Jing L, Xinyun L, Huimin Y.Stevioside
protects LPS-induced acute lung injury in mice. Inammation.
2013;36:242–50.
189. Zhu Y, He W, Gao X, Li B, Mei C, Xu R, Chen H.Resveratrol
overcomes getinib resistance by increasing the intracellular getinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells. Sci Rep. 2015;5:17730.
190. Ribeiro A, Ferraz-Paula V, Pinheiro ML, Vitoretti LB, Souza
MDP, Quinteiro-Filho WM, Akamine AT, Almeida VI, Quevedo
J, Dal-Pizzol F, Hallak JE, Zuardi AW, Crippa JA, PalermoNeto J.Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inammation in a murine model of acute lung
injury: role for the adenosine A(2A) receptor. Eur J Pharmacol.
2012;678:78–85.
191. San Z, Fu Y, Li W, Zhou E, Li Y, Song X, Wang T, Tian Y, Wei
Z, Yao M, Cao Y, Zhang N.Protective effect of taraxasterol on
acute lung injury induced by lipopolysaccharide in mice. Int
Immunopharmacol. 2014;19:342–50.
192. Wei D, Huang Z. Anti-inammatory effects of triptolide
in LPS-induced acute lung injury in mice. Inammation.
2014;37:1307–16.
193. Kancherla N, Dhakshinamoothi A, Chitra K, Komaram
RB.Prelimanary analysis of phytoconstituents and evaluation of
anthelminthic property of Cayratia auriculata (in vitro). Maedica
(Bucur). 2019;14:350–6.
194. Wocheslander S, Groß F, Scholz B, Engel K. Quantitation of
acyl chain oxidation products formed upon thermo-oxidation of
phytosteryl/-stanylOleates and linoleates. J Agric Food Chem.
2017;65(11):2435–42.
195. Szydłowska-Czerniak A, Tułodziecka A. Optimization of
ultrasound-assisted extraction procedure to determine antioxidant capacity of rapeseed cultivars. Food Anal Methods.
2014;8(3):778–89.
196. Fansworth NR, Fongs HNS, Tin-Wa N, Dobberstein
RH. Phytochemical screening methods. Chicago: University of
IIinois Press; 1977.
197. Popova IE, Hall C, Kubátová A.Determination of lignans in axseed using liquid chromatography with time-of-ight mass spectrometry. J Chromatogr A. 2009;1216:217–29.
198. Verpoorte R, Schripsema J.Isolation, identication, and structure
elucidation of alkaloids a general overview. In: Linskens, Jackson,
editors. Modern methods of plant analysis, vol. 15. Alkaloids.
Berlin: Springer; 1994.
199. Christophoridou S, Dais P, Tseng L-H, Spraul M.Separation and
identication of phenolic compounds in olive oil by coupling
high-performance liquid chromatography with postcolumn solidphase extraction to nuclear magnetic resonance spectroscopy
(LC-SPE-NMR). J Agric Food Chem. 2005;53:4667–79.
200. Beckey HD. 1-Theory of eld ionization (FI) and eld emission
(FE). Bergama: Pergamon; 1971.
201. Beckey HD. 2–Field ionization sources. Bergama: Pergamon;
1971.
202. Beckey HD. 3-Application of the FI mass spectrometer to physicochemical problems. Bergama: Pergamon; 1971.
203. Beckey HD. 4-Qualitative analyses with the FI mass spectrometer.
Bergama: Pergamon; 1971.
204. Kemp W. Energy and electromagnetic spectrum. In: Kemp W,
editor. Organic spectroscopy. London: Macmillan Press; 1991.
p.1–7.
205. Banu SK, Cathrine L.General techniques involved in phytochemical Analysis. IJARCS. 2015;2:25–32.
206. Kemp W. Infrared spectroscopy. In: Organic spectroscopy.
London: Macmillan Press Ltd.; 1991. p.19–56.
Chemical Characterization ofPhytoconstituents forLifestyle Diseases
https://t.me/medicina_free
87
207. Urbano M, Luque de Castro MD, Pérez PM, García-Olmo J,
Gómez-Nieto MA. Ultraviolet-visible spectroscopy and pattern recognition methods for differentiation and classication of
wines. Food Chem. 2006;97:166–75.
208. Grifths PR, de Haseth JA.Fourier-transform infrared spectrometry. Science. 2007;222:297–302.
209. Massa W. Crystal structure determination (2nd completely
updated ed.). NewYork: Springer; 2004.
210. Schripsema J, Verpoorte R.Rapid identication of trace amounts
of indole alkaloids: analysis of the aromatic pattern from the 1HNMR spectrum. In: Atta-ur-Rahman, editor. Studies in natural
products chemistry, vol. 9. Amsterdam: Elsevier; 1991. p.163–99.
211. Sangster AW, Stuart KL.Ultra-violet spectra of alkaloids. Chem
Rev. 1965;65:69–130.
212. Crab TA, Newton RF, Jackson D. Stereochemical studies
of N-bridgehead compounds by spectral means. Chem Rev.
1971;71:109–26.
213. Hesse M. Progress in mass spectrometry, vol 1, parts 1 and 2.
Mass spectrometry of indole alkaloids. Weinheim: Verlag Chemie;
1974.
214. Hesse M, Bernhard HO. Progress in mass spectrometry, vol 3.
Mass spectrometry of alkaloids. Weinheim: Verlag Chemie; 1975.
215. Shamma M, Hindenlang DM.Carbon-13 NMR shift assignments
of amines and alkaloids. NewYork: Plenum; 1979.
216. Schripsema J, Verpoorte R, Baerheim Svendsen A.Triuoroacetic
acid, a 1H-NMR shift reagent for alkaloids. Tetrahedron Lett.
1986;27:2523–6.
217. Bankeu JJK, Kagho DUK, Fongang YSF, Toghueo RMK,
Mba’ning BM, Feuya GRT, Fekam FB, Tchouankeu JC, Ngouela
SA, Sewald N, Lenta BN, Ali MS.Constituents from Nauclea lati-
folia with anti-Haemophilus inuenzae Type b inhibitory activi-
ties. J Nat Prod. 2019;82:2580–5.
218. Shigemori H, Kagata T, Ishiyama H, Morah F, Ohsaki A,
Kobayash J.Nucleamides A-E, new monoterpene indole alkaloids
from Nauclea latifolia. Chem Pharm Bull. 2003;51:58–61.
219. Bankeu JJK, Madjouka S, Feuya GRT, Fongang YSF, Siddiqui
S, Iftikhar A, Mehreen L, Lenta BN, Sammer Y, Noungoué DT,
Ngouela A, Shaiq MA.Pobeguinine: a monoterpene indole alkaloid and other bioactive constituents from the stem bark of Nauclea
pobeguinii. Zeitschrift für Naturforschung C. 2018;73:335–44.
220. Bondonno CP, Croft KD, Ward N, Considine MJ, Hodgson
JM.Dietary avonoids and nitrate: effects on nitric oxide and vascular function. Nutr Rev. 2015;73:216–35.
221. Carocho M, Ferreira CFI. The role of phenolic compounds in
the ght against cancer-a review. Anticancer Agents Med Chem.
2013;13:1236–58.
222. Bruneton J. Pharmacognosie, Phytochimie, Plantes médicinales. 4th ed. Paris: Technique et Documentation, Lavoisier; 2009.
p.1288.
223. Markham KR.Techniques of avonoids identication. London:
Academic Press; 1982.
224. Markham KR. Flavones, avonols and their glycosides. In:
Dey PP, Harborne JB, editors. Methods in plant biochemistry.
Academic Press; 1989. p.197–232.
225. Harborne JB, Williams CA.Advances in avonoid research since
1992. Phytochemistry. 2000;55:481–504.
226. Agrawal K, Markham R.Carbon-13 NMR of avonoids: introduction. In: Agrawal PK, editor. Studies in organic chemistry;
1989. p.1–40.
227. Markhan KR, Mabry TJ.Ultraviolet-visible and proton magnetic
resonance spectroscopy of avonoids. In: Harborne JB, Mabry TJ,
Mabry H, editors. The avonoids. London: Chapman and Hall;
1975. p.45–77.
228. Markham R, Geiger H. 1H-NMR spectroscopy of avonoids and
their glycosides, in hexadeuterodimethylsulfoxide. In: The avonoids. Edition Harborne. London: Chapman and Hall; 1993.
p.33–99.
229. Agrawal PK.Flavonoid structure and carbon-13 NMR spectroscopy. In: Agrawal PK, editor. Carbon 13-NMR of avonoids.
NewYork: Elsevier; 1989.
230. Levy GC, Nelson GL.Carbon-13 nuclear magnetic resonance for
organic chemists. NewYork: Wiley; 1972. p.80–1.
231. Markham KR, Chari VM.Carbon-13 NMR spectroscopy of avonoids (Chap 2). In: Harborne JB, etal., editors. The avonoids.
Dordrecht: Springer; 1982. p.19–134.
232. Manasa G.Structural elucidation of terpenoids by spectroscopic
techniques. JCHPS. 2014;5:36–7.
233. Hamimed S.Caractérisation chimique des principes à effet antidermatophyte des racines d’Anacyclus pyrethrum L. Mémoire
Présenté pour L’obtention du diplôme de Magister en chimie
organique, option: Substances thérapeutique d’origine naturelle,
faculté des sciences exactes département de chimie. Algérie:
Universite Mentouri Constantine; 2009. p.24–31.
234. Bory S, Fetizon M.Bull Soc Chim Fr. 1964;11:3458.
235. Ogunkoya L.Application of mass spectrometry in structural problems in triterpenes. Phytochemistry. 1980;20:121–6.
236. Simla B. Phytochemical investigations on Boswellia species: comparative studies on the essential oils, pyrolysates and
boswellic acids of Boswellia carterii Birdw., Boswellia serrata
Roxb., Boswellia frereana Birdw., Boswellia neglecta S.Moore
and Boswellia rivae Engl. dissertation for the fulllment of the
requirements for the degree of Dr. rer. nat. Allemagne: University
of Hamburg; 2005. p.160–169.
237. Bruneton J.Pharmacognosie, phytochimie, plantes médicinales.
2nd ed. Paris: France Édition Tech. et Doc; 1999. p.266–80.
238. Connolly J, Hill A. Methods in plants biochemistry, vol. 7.
NewYork: Academy Press; 1991. p.331–59.
239. Mahato S, Kundu A. 13C-MMR spectra of pentacyclic triterpenoids. A compilation and some salient features. Phytochemistry.
1994;37:1517–75.
240. Agrawal PK, Jain DC, Gupta RK, Thakur RS.Carbon-13 NMR
spectroscopy of steroidal sapogenins and steroidal saponins.
Phytochemistry. 1985;24:2479–96.
241. Sang S, Lao A, Wang H, Chen Z.Two new spirostanol saponins
from Allium tuberosum. J Nat Prod. 1999;62:1028–9.
Role ofMedicinal Plants
https://t.me/medicina_free
intheManagement ofDiabetes Mellitus
SarojSinghmura, SouvikBasak, andNilanjanGhosh
Abstract
Since ancient times, cure or prevention of diseases by
medicinal plants was being practiced by indigenous people of different communities around the world through
their traditional approaches. The development of civilization and humankind has shown the path of dening properties of medicinal plants and improvement in dealing
with different diseases by the identication of responsible
molecules. Diabetes mellitus (DM) represents a signicant metabolic disorder of considerable concern. The disruption of insulin action in maintaining glucose
homeostasis arises from elevated blood glucose levels,
which can result from defects in insulin synthesis, secretion, binding to receptors, or increased insulin resistance.
Other risk factors, such as obesity, urbanization, and
genetic mutations, can further contribute to the development of DM. To counter this pathophysiological condition, several marketed remedies are available, but they
limit their uses because of their expensive and several
complications. On the other hand, the management of diabetes mellitus by herbal medicines is less cost-effective
and the complications are also rare.
Keywords
Bioactive phytoconstituents · Glucose metabolism ·
Medicinal plants · Insulin resistance · Diabetes mellitus
S. Singhmura · S. Basak
Dr. B.C. Roy College of Pharmacy and AHS, Durgapur, India
N. Ghosh (*)
Department of Pharmaceutical Technology, Jadavpur University,
Kolkata, India
e-mail: nilanjanghosh.phamacy@jadavpuruniversity.in
1 Introduction
Diabetes mellitus is a persistent metabolic disorder
marked by increased levels of blood glucose resulting
from inadequate insulin production or ineffective utilization of insulin by the body and has become a global health
concern. Globally, over 400 million people are currently
affected by diabetes, and projections suggest this number
may rise to 640 million by the year 2040. The impact of
this disease is staggering, encompassing both public
health expenses for diabetic patient care and the personal
costs associated with severe complications. Approximately
90% of all diabetes cases are type 2 diabetes mellitus
(T2DM) and are characterized by obesity, insulin resistance, and a gradual decline in insulin secretion. Genetic
predisposition, age, obesity, improper dietary habits, and
sedentary lifestyles are among the most signicant factors
contributing to the development of this condition. Thus,
managing diabetes effectively is crucial to prevent complications and improve the quality of life for those living
with the condition. The growing interest in natural and
alternative therapies for diabetes management is a necessity of the time because of the side effects and economic
burden of its management and hence medicinal plants
have emerged as promising candidates in this regard. For
centuries, traditional medicine systems have recognized
the therapeutic potential of various plant species in controlling blood sugar levels and alleviating diabetes-related
symptoms. The role of medicinal plants in managing diabetes mellitus is multifaceted. Within these medicinal
plants, a rich assortment of bioactive compounds, including alkaloids, avonoids, anthraquinone, saponins, glycosides, and carbohydrates, has been identied, exhibiting
remarkable antidiabetic properties. Scientic research has
focused on investigating the mechanisms of action of
these compounds and their potential benets in regulating
glucose metabolism, enhancing insulin sensitivity, and
reducing insulin resistance.
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
A. K. Dhara, S. C. Mandal (eds.), Role of Herbal Medicines, https://doi.org/10.1007/978-981-99-7703-1_5
89
90
https://t.me/medicina_free
S. Singhmura et al.
2 Background: Blood Glucose
Homeostasis andIts Faith inDiabetes
Mellitus
Insulin maintains blood glucose homeostasis by taking into
the cells, thus its level is maintained. If this regulation is disturbed, it results in a hyperglycemic state, and if not regulated, prolonged exposure may lead to chronic complications
affecting the renal, neurological, gastrointestinal, genitourinary, cardiovascular system, and lower extremity [1]. In individuals without diabetes, the blood glucose concentration is
meticulously controlled to provide a constant energy source
for various tissues and organs. Insulin and glucagon, the primary hormones responsible for this equilibrium, are both
secreted by the pancreas' β cells. Their release is triggered by
a complex interplay of metabolic, hormonal, neuronal, and
pharmacological factors, working through interconnected
intracellular signaling pathways.
2.1 Pathways ofInsulin Secretion
The secretion of insulin is a highly controlled process aimed
at maintaining stable blood glucose levels during fasting and
feeding periods. This delicate regulation relies on the orchestrated interaction between glucose and non-nutrient secretagogues, such as neurotransmitters and hormones.
2.1.1 Pathway ofInsulin Secretion Induced by
Glucose Stimulation
The homeostatic blood glucose level is upheld by insulin
released by the beta (β) cells within the pancreatic islets of
Langerhans. Insulin plays a pivotal role in governing the
body's metabolism of carbohydrates, proteins, and fats. Its
main function involves facilitating the uptake of carbohydrates, predominantly glucose, from the bloodstream into
skeletal muscle, adipose tissue, and the liver. When foods
containing carbohydrates are ingested, enzymatic processes
trigger a rise in blood glucose levels, which is detected by
beta (β) cells (Fig.1). Subsequently, these cells take up glucose from the bloodstream via glucose transporters (GLUTs)
and engage in glycolysis, leading to an increase in ATP production [2, 3]. Elevated levels of this leads to the suppression
of the cell's K
channels. [4, 5]. K
ATP
channels are made up
ATP
of two different proteins: sulfonylurea receptor (SUR) subunits and pore-forming (Kir6.x) subunits (Figs. 2 and 3).
Channel activity is stimulated by Mg-nucleotide binding/
hydrolysis at the nucleotide-binding domains (NBD1 and
NBD2) of SUR subunit [6]. The closure of the pore in Kir6.2
is induced by the binding of ATP or ADP, and this effect does
not depend on Mg2+. Consequently, the closure of KATP
channels results in depolarization and subsequent activation
of L-type Ca2+ channels. This activation permits an inux of
Ca2+ into the cell [5, 7–9], followed by exocytotic release of
insulin [10]. This exocytosis of insulin from β-cells is rapid,
taking place within the rst 5–10 min, commonly known as
the rst phase of secretion. Following this, a sustained
release, known as the second phase secretion, occurs. The
signicance of the second phase lies in its potential to
become quantitatively signicant, as it can be maintained for
several hours in cases where elevated blood glucose levels
persist [11]. In addition to the insulin secretion mechanism
mentioned above, it is important to acknowledge that glucose can stimulate insulin release through other means.
Notably, any alterations in the channels present in β-cells
that impact membrane potential could also inuence the
movement of Ca2+ into the cytosol, thereby inuencing insulin secretion [12–14].
Fig. 1 Insulin secretion
Role ofMedicinal Plants intheManagement ofDiabetes Mellitus
https://t.me/medicina_free
91
Fig. 2 K
Fig. 3 K
channel (stimulate)
ATP
channel (closed)
ATP
2.2 Gut Hormone Pathway
Incretins are gastrointestinal hormones released in response
to food intake. Glucagon-like peptide-1 (GLP-1) is secreted
from enteroendocrine L cells, which are distributed throughout the small and large intestines. Similarly, glucosedependent insulinotropic polypeptide (GIP) is secreted from
enteroendocrine K cells in the duodenum and jejunum. Once
released, these incretins bind to their specic G-proteincoupled receptors, leading to the activation of adenylate
cyclase and subsequent elevation of intracellular cAMP levels [15], followed by activation of PKA (protein kinase A)
and cAMP-binding proteins referred to as cAMP-regulated
guanine nucleotide exchange factors (cAMP GEFs), also
known as Epac2 (Exchange protein directly activated by
cAMP 2) or cAMP-GEFII [16]. PKA activation is believed
to facilitate exocytotic release of insulin [17–19].
Dipeptidyl peptidase-4 (DPP4) (Fig.4) is an extensively
distributed enzyme that exerts its actions through both a
membrane-anchored transmembrane molecule and a soluble
circulating protein [15]. DPP4 plays a signicant role in glucose homeostasis. By breaking down these incretin hormones, DPP4 reduces their ability to promote insulin
secretion, leading to decreased insulin release and impaired
glucose clearance from the bloodstream. Overall, the regulatory role of DPP4in incretin hormone metabolism and glucose homeostasis highlights its signicance in maintaining
proper blood glucose levels in the body.
92
https://t.me/medicina_free
Fig. 4 Dipeptidyl peptidase-4
(DPP-4) enzyme
S. Singhmura et al.
3 Regulation Glucose Level
3.1 Enzymatic Action
Carbohydrates constitute the primary components of the
typical human diet. Among its major forms, starch and
sucrose contribute around 70–80% of the body’s energy
requirements. The digestion of carbohydrates begins in the
mouth and continues in the small intestine, resulting in the
production of glucose. This glucose is then absorbed into the
bloodstream through the enzymatic action within the intestinal walls and subsequently transported to various body parts,
facilitated by the liver. Polysaccharides (starch) is converted
into maltose, sucrose, and lactose (Disaccharides) and then
nally into glucose, the main digested product, along with
small amount of fructose and galactose (monosaccharides).
The breakdown of starch initially occurs through α-amylase,
an enzyme presents in saliva and pancreatic juices, which
converts it into oligosaccharides. Subsequently, a membranebound enzyme called α-glucosidase, found in the small
intestine's epithelium, catalyzes the cleavage of glucose from
disaccharides and oligosaccharides, leading to postprandial
hyperglycemia. Due to this process, inhibiting α-amylase
and glucosidase can be an effective treatment for diabetes.
By doing so, the absorption of glucose is delayed, which can
be benecial for individuals with impaired insulin response
or production. In hepatocytes, glycolysis regulates hepatic
glucose levels. Pancreatic β cells couple glycolysis with
glucose- stimulated insulin secretion. Adipocytes utilize gly-
colysis to produce metabolites for lipogenesis and divert
excessive fatty acids away from oxidation, reducing oxidative stress. In a proinammatory state, adipocytes release
prohyperglycemic factors, leading to hyperglycemia and
insulin resistance. In hypothalamic neurons, glycolysis is
involved in nutrient sensing, which inuences feeding control. Dysregulation of glycolysis can contribute to the development of diabetes.
An imbalance in glucose-6-phosphatase activity can lead
to hyperglycemia in diabetes. Aldose reductase (AR), a cytosolic enzyme, normally performs several essential functions,
including detoxifying harmful aldehydes in extrahepatic tissues, producing fructose for sperm, maintaining osmoregulatory balance in the kidney, and reducing steroids and
catecholamines. However, under certain conditions, AR catalyzes the NADPH-dependent reduction of glucose to sorbitol in the polyol pathway, resulting in an overproduction of
reactive oxygen species (ROS). This increased ROS production can contribute to oxidative stress and other detrimental
effects, potentially exacerbating the complications of diabetes [20]. Converted sorbitol poorly penetrates membranes,
and thus if blood glucose rises, it causes intracellular accumulation along with its metabolites fructose, which creates
osmotic swelling and cell dysfunction [21]. Overuse of
polyol metabolism may cause hyperglycemia, sorbitoland
osmotic buildup,which can all contribute to cataract development. [22–24]. Protein Tyrosine Phosphatase 1B (PTP1B)
is a phosphatase situated on the cytoplasmic side of the endoplasmic reticulum (ER) [25]. Expressed in various tissues,
Role ofMedicinal Plants intheManagement ofDiabetes Mellitus
https://t.me/medicina_free
93
including skeletal muscle, liver, adipose tissue, and brain,
Protein Tyrosine Phosphatase 1B (PTP1B) plays a role in
negatively regulating multiple cellular pathways, such as the
response to insulin or endothelial nitric oxide (NO) production [17]. It functions as an essential enzyme in the dephosphorylation of tyrosine (Tyr)-phosphorylated proteins,
making it a key player in the dephosphorylation of the insulin receptor (IR) and its downstream signaling components
[25]. PTP1B has been identied as a key enzyme responsible
for the dephosphorylation of both IR and its downstream signaling component, IRS-1. Disruptions in this pathway can
lead to diverse metabolic disorders, including insulin resistance and type 2 diabetes.
3.2 Advance Glycation End Products
The accumulation of advanced glycation end products
(AGEs) arises from the reaction between carbonyl groups of
reducing sugars and amino groups of proteins, lipids, and
nucleic acids. This cellular dysregulation occurs in diabetes,
leading to various complications such as cardiomyopathy,
neuropathy, retinopathy, and nephropathy, as well as contributing to atherosclerosis and aging. The presence of AGEs
inuences the expression of genes, intracellular signals, and
the release of proinammatory molecules and reactive oxygen species (ROS), further exacerbating the impact on cellular function and contributing to the development of diabetic
complications and other age-related diseases.
3.3 Oxidative Stress
Hyperglycemia can initiate tissue damage through ve signicant mechanisms, all stemming from a single upstream
event: mitochondrial overproduction of reactive oxygen species (ROS) [26].
1. Increased formation of AGEs: Elevated ROS levels in the
mitochondria can lead to increased formation of AGEs.
These harmful compounds can accumulate in tissues,
causing oxidative stress, inammation, and damage to
proteins, lipids, and DNA [27].
2. Activation of Protein Kinase C (PKC): Hyperglycemiainduced ROS production which can activate certain
enzymes, such as PKC. Overactivated PKC can further
promote inammation, disrupt cell signaling pathways,
and contribute to tissue damage.
3. Increased polyol pathway activity: Mitochondrial-derived
ROS can enhance the activity of the polyol pathway, lead-
ing to the accumulation of sorbitol in tissues. This can
cause osmotic stress and damage to nerve cells, blood
vessels, and other structures [28].
4. Altered cellular metabolism and mitochondrial dysfunction: High levels of ROS can disrupt cellular metabolism
and lead to mitochondrial dysfunction. Impaired mitochondria affect the production of ATP, causing energy
depletion and contributing to cellular damage [29].
5. Increased expression of the receptor for advanced glycation end products (RAGE). RAGE is a cell surface receptor that binds to AGEs formed as a result of prolonged
exposure to high glucose levels. When blood glucose levels are elevated, the formation of AGEs is increased.
These AGEs can bind to RAGE on the cell surface, leading to several detrimental effects [30]. Antioxidant ther-
apy in diabetes involves the modulation of various cellular
processes affected by oxidative stress and it can be
achieved by neutralization of Reactive Oxygen Species
(ROS). Antioxidants directly scavenge and neutralize
reactive oxygen species (ROS) generated during oxidative stress. Restoration of antioxidant enzymes by natural
antioxidants can help restore the activity of endogenous
antioxidant enzymes, such as superoxide dismutase
(SOD), catalase, and glutathione peroxidase. These
enzymes play a crucial role in neutralizing ROS and
maintaining cellular redox balance. Antioxidant therapy
can enhance the activity of these enzymes, further bolstering the cellular defense against oxidative stress.
Moreover, it can be done by inhibition of advanced glycation end products (AGEs) formation. Some antioxidants,
such as alpha-lipoic acid, have been shown to inhibit the
formation of AGEs. AGEs are harmful compounds that
form when glucose reacts with proteins, and they contribute to tissue damage and diabetic complications. By
reducing AGEs formation, antioxidants can help mitigate
their detrimental effects on tissues. Antioxidants can further modulate inammatory pathways by reducing the
expression of pro-inammatory molecules, such as cytokines and adhesion molecules. By suppressing inammation, antioxidants can help protect tissues from
inammatory damage seen in diabetes-related complications. Antioxidant can improve mitochondrial function to
reduce oxidative damage within these vital cellular organelles. Improving mitochondrial function contributes to
overall cellular health and energy production and
improves insulin sensitivity and glucose uptake in cells.
By enhancing insulin signaling pathways, antioxidants
may contribute to better glucose regulation in diabetes
[31].
94
https://t.me/medicina_free
S. Singhmura et al.
4 Antidiabetic Phytoconstituents
andTheir Mode ofAction (Fig.5)
Phytoconstituents, or phytochemicals, are natural chemical
compounds that naturally occur in plants. These compounds
play a vital role in the biological activities of plants and are
responsible for their diverse medicinal properties.
Researchers are actively isolating various phytoconstituents
and exploring their potential to develop strategies for managing diabetes mellitus. Isolated phytoconstituents can be classied into several classes based on their chemical structures
and properties, such as alkaloids, avonoids, anthraquinones,
glycosides, saponins, coumarins, and more. This categorization helps in better understanding and utilizing the diverse
therapeutic potentials of these plant-derived compounds in
the management of diabetes and related conditions (Tables 1
and 2).
4.1 Alkaloids
Among the prominent natural product categories, alkaloids
are extensively isolated from medicinal plants and have demonstrated the ability to regulate glucose metabolism in animal models. This research is instrumental in comprehending
and developing strategies for managing diabetes mellitus and
its complications. Isolated alkaloids and their derivatives
have exhibited various modes of antidiabetic activity. These
include enhanced insulin secretion, improved digestion and
absorption of carbohydrates, increased liver glycogen, regeneration of β-cells, inhibition of α-glucosidase, elevated glucose transporter concentration, and inhibition of digestive
enzymes. These diverse mechanisms underscore the potential of alkaloids as valuable resources for the development of
novel treatments in the realm of diabetes management.
4.1.1 Inhibition ofEnzymes
Secondary metabolites isolated from medicinal plants can
inhibit digestive enzymes (Sect. 3.1) and thereby help lower
postprandial blood glucose levels [90]. These compounds
prevent the formation of enzyme-substrate complexes, leading to reduced enzyme activity. For example, carbazole alkaloids from Murraya koenigii L.Spreng (Table2) demonstrate
α-glucosidase inhibition, and mahanimbine exhibits
α-amylase and α-glucosidase inhibitory effects, potentially
benecial in managing diabetes-associated cardiovascular
complications [90]. Several other alkaloids have been found
to effectively stimulate glucose uptake in skeletal muscles,
both insulin-dependent and insulin-independent, such as
O-methylmurrayamine A [48], koenidine [75], mahanimbine
[91], and murrayazoline are found to be effectively stimulating glucose uptake in skeletal muscles (measured in
L6-GLUT4myc myotubes). These carbazole alkaloids
increase in the surface GLUT4myc level [92]. Allylpropyl
disulde isolated from Allium sativumis is involved in glycogen synthesis and insulin secretion. Adhatoda vasica (Nees.)
isolated alkaloids like quinazoline, vasicine, and vasicinol
have shown to inhibit rat intestinal α-glucosidase competitively [32]. Palmatine is a bioactive protoberberine alkaloid,
which was isolated from Coscinium fenestratum stem extract
that has effective alpha-amylase, alpha-glucosidase, and
DPP-IV inhibitor activity, which may be helpful to reduce
the postprandial glucose level [77]. Oriciopsis glaberrima
showed an α-glucosidase inhibitory activity due to
Oriciacridone C, 1,3,5-trihydroxy-4-(c,c-dimethylallyl)acridone and oriciacridone F [93]. Piper umbellatum shows
the α-glucosidase inhibitory activity due to the presence of
three alkaloid piperumbellactam A, B, and C found in the
fraction of the extract from the branches of the plant [94].
Indole alkaloids vindogentianine obtained from leaf extract
in Catharanthus roseus (L.) Gis are able to inhibit both the
Fig. 5 Mode of action of phytoconstituents in the management of diabetes mellitus
Соседние файлы в папке Библиотека им академика М.И. Перельмана